StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3025% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Total U.S. Industry MAUDE Device Adverse Event Reports by Year

Total U.S. Industry MAUDE Device Adverse Event Reports (U.S. Industry Total MDRs)

Thermo Fisher Scientific Total U.S. Industry MAUDE Device Adverse Event Reports: 2,888,003 in FY2025, up 9.9% from a year earlier.

Latest, FY2025
2,888,003
Period ended Dec 31, 2025
Change on a year earlier
+9.9%
2,627,151 in FY2024
History
10 years
Since FY2016
Sources
1
openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total

Where the FY2025 figure comes from

Source: openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗

Reported in U.S. FDA openFDA MAUDE Adverse Event API.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Thermo Fisher Scientific Total U.S. Industry MAUDE Device Adverse Event Reports, annual FY2016–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/fda-maude-industry

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.